Diabetes-2 (1) Flashcards

1
Q

What are incretins?

A

Hormones that mediate communication between gut and brain

Incretins include GLP-1 and GIP, which play roles in insulin secretion and appetite regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List examples of incretins.

A
  • Glucagon-like peptide-1 (GLP-1)
  • Glucose-dependent insulinotropic peptide (GIP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of incretin-based therapies?

A
  • GLP-1 agonists
  • Dipeptidyl peptidase 4 (DPP-4) inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the prototype GLP-1 agonist?

A

Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What potential benefit does liraglutide have beyond diabetes management?

A

May reduce risk of cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the prototype DPP-4 inhibitor?

A

Sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List other examples of DPP-4 inhibitors.

A
  • Saxagliptin
  • Linagliptin
  • Alogliptin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the mechanism of incretins in insulin release.

A

Incretins augment glucose-stimulated insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do incretins affect blood glucose levels?

A

They stimulate insulin release in a glucose-dependent manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the administration method for DPP-4 inhibitors?

A

Orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How were GLP-1 agonists traditionally administered?

A

Subcutaneous injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What recent change occurred in the administration of GLP-1 agonists?

A

Approval of an oral form of semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is SNAC in the context of oral peptide delivery?

A

Sodium N-(80[2-hydroxybenzoyl] amino) caprylate, a permeation enhancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the gastrointestinal side effects of GLP-1 agonists?

A
  • Nausea
  • Vomiting
  • Diarrhea (or constipation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: DPP-4 inhibitors have more gastrointestinal side effects than GLP-1 agonists.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a common side effect of DPP-4 inhibitors?

A

Upper respiratory tract or urinary tract infections

17
Q

What is the prototype thiazolidinedione (TZD)?

A

Pioglitazone

18
Q

What do PPAR-γ agonists regulate?

A

Genes related to glucose and lipid metabolism

19
Q

What is the primary action of thiazolidinediones?

A

Increase insulin sensitivity

20
Q

How do TZDs reduce hepatic glucose production?

A

By increasing sensitivity of cells to insulin

21
Q

List some side effects of thiazolidinediones.

A
  • Cardiovascular issues
  • Edema
  • Weight gain
  • Fractures in women
22
Q

What is the prototype alpha-glucosidase inhibitor?

23
Q

What is the mechanism of action of alpha-glucosidase inhibitors?

A

Inhibit breakdown of carbohydrates, preventing absorption

24
Q

What are common side effects of alpha-glucosidase inhibitors?

A
  • Bloating
  • Diarrhea
  • Pain
25
What is the mechanism of action of SGLT2 inhibitors?
Inhibit renal reabsorption of glucose
26
What is the prototype SGLT2 inhibitor?
Empagliflozin
27
List some effects of SGLT2 inhibitors.
* Reduce blood glucose * Induce weight loss * May reduce blood pressure
28
What is a common side effect of SGLT2 inhibitors related to infections?
Increased risk of urinary tract infections
29
What is the benefit of combination therapy in T2DM?
Can enhance effectiveness and mitigate side effects
30
What combinations can be made with Metformin?
* Metformin + Insulin * Metformin + Sulfonylurea
31
Combining GLP-1 agonists with insulin reduces the risk of _______.
Hypoglycemia